Key result
Smartphone MCG-detected AF recurrence links to a ~6-fold higher rate of 12-month re-ablation.
Why the study?
AF recurrence following catheter ablation may be underdetected by conventional intermittent monitoring, and evidence regarding the real-world applicability of smartphone-based mechanocardiography in the post-ablation setting remained limited.
Does smartphone-based mechanocardiography home monitoring effectively detect atrial fibrillation recurrence and predict re-ablation in patients undergoing catheter ablation for atrial fibrillation?
Cohort (n=640)
No
Does smartphone-based mechanocardiography home monitoring effectively detect atrial fibrillation recurrence and predict re-ablation in patients undergoing catheter ablation for atrial fibrillation?
Smartphone-based mechanocardiography is a feasible, well-accepted post-ablation home monitoring tool where detected early AF recurrence strongly predicts the need for re-ablation within 12 months.
High initial engagement supports smartphone monitoring feasibility post-ablation; leaves open whether it reduces repeat procedures.
Aims Recurrence of atrial fibrillation (AF) following catheter ablation is common but may be underdetected using conventional intermittent monitoring. Smartphone-based Mechanocardiography (MCG) enables low-burden rhythm assessment; however, evidence regarding its real-world applicability in the post-ablation setting remains limited. We aimed to evaluate the feasibility, usability, and clinical relevance of MCG-based home monitoring after AF ablation, and to explore its association with re-ablation. Methods and results In this prospective single-center study, 640 consecutive patients with paroxysmal and persistent AF undergoing AF ablation were offered home monitoring using the CardioSignal® smartphone application. Among these, 521 (81%) were active users during the first month, and 354 (68%) remained active at 6 months. 8,240 recordings were performed in the first month, declining to 2,869 at 6 months. AF recurrence was detected in 40% of active users during the first 3 months and in 30% during months 4-6, with clear early clustering. Usability was high: 95% of survey respondents (n=338) reported the app was easy to use, and 91% perceived monitoring as valuable. In a predefined Danish subcohort (n=164), Kaplan-Meier survival analysis demonstrated early AF recurrence detected by MCG was strongly associated with re-ablation within 12 months (log-rank p< 0,0002), occurring in 27.6% of patients with early AF recurrence vs. 4.5% without. Conclusion Smartphone-based MCG is a feasible, well-accepted method for patient-initiated, low-burden event monitoring. Early AF recurrence detected by MCG is common and associated with re-ablation, supporting its role in early risk stratification and post-procedural management.
No takes yet. Share an insight, caveat, or question.
Lindgren et al. (2026) conducted a cohort in Paroxysmal and persistent atrial fibrillation undergoing catheter ablation (n=640). Smartphone-based Mechanocardiography (CardioSignal) home monitoring / early AF recurrence vs. No early AF recurrence detected by MCG was evaluated on Re-ablation within 12 months (in the predefined Danish subcohort, n=164) (p=<0.0002). Smartphone-based MCG detected AF recurrence in 40% of active users within 3 months, which was strongly associated with 12-month re-ablation (27.6% vs 4.5%; P<0.0002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: